tiprankstipranks
Trending News
More News >
Jiangsu Recbio Technology Co., Ltd. Class H (HK:2179)
:2179
Hong Kong Market

Jiangsu Recbio Technology Co., Ltd. Class H (2179) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Jiangsu Recbio Technology Co., Ltd. Class H
HK$5.48
HK$2.63B
-3.72
-33.82%
TOT BIOPHARM International Co. Ltd.
HK$1.94
HK$1.50B
189.52
16.37%
0 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$5.28
HK$9.81B
-47.25
62.20%
1 Buy
0 Hold
0 Sell
Moderate Buy
CStone Pharmaceuticals
HK$5.59
HK$8.12B
-18.03
110.49%
1 Buy
0 Hold
0 Sell
Moderate Buy
SinoMab Bioscience Ltd.
HK$1.49
HK$2.05B
-10.23
40.00%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
5.48
-2.52
-31.50%
HK:1875
TOT BIOPHARM International Co. Ltd.
1.99
0.34
20.61%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.32
2.04
62.20%
HK:2616
CStone Pharmaceuticals
5.62
3.06
119.53%
HK:3681
SinoMab Bioscience Ltd.
1.47
0.42
40.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts